Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Current Medicinal Chemistry|February 7, 2003
Drugs that activate specific nitric oxide sensitive guanylyl cyclase isoforms independent of nitric oxide releaseSönke BehrendsBiochemical Pharmacology|July 11, 2002
Biliverdin IX is an endogenous inhibitor of soluble guanylyl cyclaseMarkus Koglin, Sönke BehrendsThe Journal of Biological Chemistry|February 1, 2003
A functional domain of the alpha1 subunit of soluble guanylyl cyclase is necessary for activation of the enzyme by nitric oxide and YC-1 but is not involved in heme bindingMarkus Koglin, Sönke BehrendsBiochemical Pharmacology|March 26, 2004
Native human nitric oxide sensitive guanylyl cyclase: purification and characterizationMarkus Koglin, Sönke BehrendsBiochimica Et Biophysica Acta. Proteins and Proteomics|April 14, 2018
Synergistic stabilisation of NOsGC by cinaciguat and non-hydrolysable nucleotides: Evidence for sGC activator-induced communication between the heme-binding and catalytic domainsAnne Sömmer, Sönke BehrendsBiochemical Pharmacology|July 17, 2026
Chimeric analysis links increased NO sensitivity to GC-2 domains and higher maximal activity to GC-1Svenja Stomberg, Sönke BehrendsPlatelets|January 10, 2004
Analysis of nitric oxide-sensitive guanylyl cyclase in human platelets before and after aggregationJörg Kempfert, Sönke BehrendsNitric Oxide : Biology and Chemistry|April 30, 2018
Methods to investigate structure and activation dynamics of GC-1/GC-2Anne Sömmer, Sönke BehrendsThe Journal of Biological Chemistry|November 14, 2013
Nitric oxide activation of guanylate cyclase pushes the α1 signaling helix and the β1 heme-binding domain closer to the substrate-binding siteMareike Busker, Inga Neidhardt, Sönke BehrendsBiochemical Pharmacology|November 21, 2017
BAY 60-2770 activates two isoforms of nitric oxide sensitive guanylyl cyclase: Evidence for stable insertion of activator drugsAnne Sömmer, Peter Sandner, Sönke BehrendsPageof 4